Partin AW - Search Results

1

Fifth-generation digital immunoassay for prostate-specific antigen by single molecule array technology.

Wilson DH, Hanlon DW, Provuncher GK, Chang L, Song L, Patel PP, Ferrell EP, Lepor H, Partin AW, Chan DW, Sokoll LJ, Cheli CD, Thiel RP, Fournier DR, Duffy DC. Wilson DH, et al. Among authors: partin aw. Clin Chem. 2011 Dec;57(12):1712-21. doi: 10.1373/clinchem.2011.169540. Epub 2011 Oct 13. Clin Chem. 2011. PMID: 21998342 Free PMC article.

2

Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia.

Partin AW, Carter HB, Chan DW, Epstein JI, Oesterling JE, Rock RC, Weber JP, Walsh PC. Partin AW, et al. J Urol. 1990 Apr;143(4):747-52. doi: 10.1016/s0022-5347(17)40079-6. J Urol. 1990. PMID: 1690309 Free article.

3

The relationship of prostate specific antigen levels and residual tumor volume in stage A prostate cancer.

Carter HB, Partin AW, Epstein JI, Chan DW, Walsh PC. Carter HB, et al. Among authors: partin aw. J Urol. 1990 Nov;144(5):1167-70; discussion 1170-1. doi: 10.1016/s0022-5347(17)39683-0. J Urol. 1990. PMID: 1700143

4

The influence of reversible androgen deprivation on serum prostate-specific antigen levels in men with benign prostatic hyperplasia.

Weber JP, Oesterling JE, Peters CA, Partin AW, Chan DW, Walsh PC. Weber JP, et al. Among authors: partin aw. J Urol. 1989 Apr;141(4):987-92. doi: 10.1016/s0022-5347(17)41083-4. J Urol. 1989. PMID: 2467015

5

The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer.

Partin AW, Yoo J, Carter HB, Pearson JD, Chan DW, Epstein JI, Walsh PC. Partin AW, et al. J Urol. 1993 Jul;150(1):110-4. doi: 10.1016/s0022-5347(17)35410-1. J Urol. 1993. PMID: 7685418 Free article.

6

Clearance rate of serum-free and total PSA following radical retropubic prostatectomy.

Partin AW, Piantadosi S, Subong EN, Kelly CA, Hortopan S, Chan DW, Wolfert RL, Rittenhouse HG, Carter HB. Partin AW, et al. Prostate Suppl. 1996;7:35-9. Prostate Suppl. 1996. PMID: 8950362

7

Longitudinal analysis of serial measurements of free and total PSA among men with and without prostatic cancer.

Pearson JD, Luderer AA, Metter EJ, Partin AW, Chan DW, Fozard JL, Carter HB. Pearson JD, et al. Among authors: partin aw. Urology. 1996 Dec;48(6A Suppl):4-9. doi: 10.1016/s0090-4295(96)00603-6. Urology. 1996. PMID: 8973693 Free article.

8

Multicenter comparison of the diagnostic performance of free prostate-specific antigen.

Thiel RP, Oesterling JE, Wojno KJ, Partin AW, Chan DW, Carter HB, Stamey TA, Prestigiacomo AR, Brawer MK, Petteway JC, Carlson G, Luderer AA. Thiel RP, et al. Among authors: partin aw. Urology. 1996 Dec;48(6A Suppl):45-50. doi: 10.1016/s0090-4295(96)00609-7. Urology. 1996. PMID: 8973699 Free article. Clinical Trial.

9

The role of free/total prostate-specific antigen ratio in the prediction of final pathologic stage for men with clinically localized prostate cancer.

Pannek J, Subong EN, Jones KA, Marschke PL, Epstein JI, Chan DW, Carter HB, Luderer AA, Partin AW. Pannek J, et al. Among authors: partin aw. Urology. 1996 Dec;48(6A Suppl):51-4. doi: 10.1016/s0090-4295(96)00610-3. Urology. 1996. PMID: 8973700 Free article. Clinical Trial.

10

Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection: influence of total PSA, prostate volume, and age.

Partin AW, Catalona WJ, Southwick PC, Subong EN, Gasior GH, Chan DW. Partin AW, et al. Urology. 1996 Dec;48(6A Suppl):55-61. doi: 10.1016/s0090-4295(96)00611-5. Urology. 1996. PMID: 8973701 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

613 results

Search Page

Filters